Nociceptor Neurons are Involved in the Host Response to Escherichia coli Urinary Tract Infections

References

• Öztürk R, Murt A. Epidemiology of urological infections: a global burden. World J Urol. 2020;38(11):2669–2679. doi:10.1007/s00345-019-03071-4
   PubMed Web of Science ®Google Scholar
• Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269–284. doi:10.1038/nrmicro3432
   PubMed Web of Science ®Google Scholar
• Behzadi P, Urbán E, Matuz M, Benkő R, Gajdács M. The role of gram-negative bacteria in urinary tract infections: current concepts and therapeutic options. Adv Exp Med Biol. 2021;1323:35–69. doi:10.1007/5584_2020_566
   PubMed Web of Science ®Google Scholar
• Abraham SN, Miao Y. The nature of immune responses to urinary tract infections. Nat Rev Immunol. 2015;15(10):655–663. doi:10.1038/nri3887
   PubMed Web of Science ®Google Scholar
• Wu J, Miao Y, Abraham SN. The multiple antibacterial activities of the bladder epithelium. Ann Transl Med. 2017;5(2):35. doi:10.21037/atm.2016.12.71
   PubMed Web of Science ®Google Scholar
• Haraoka M, Hang L, Frendeus B, et al. Neutrophil recruitment and resistance to urinary tract infection. J Infect Dis. 1999;180(4):1220–1229. doi:10.1086/315006
   PubMed Web of Science ®Google Scholar
• Schiwon M, Weisheit C, Franken L, et al. Crosstalk between sentinel and helper macrophages permits neutrophil migration into infected uroepithelium. Cell. 2014;156(3):456–468. doi:10.1016/j.cell.2014.01.006
   PubMed Web of Science ®Google Scholar
• Mulvey MA, Lopez-Boado YS, Wilson CL, et al. Induction and evasion of host defenses by type 1-Piliated uropathogenic Escherichia coli. Science. 1998;282:1494–1497. doi:10.1126/science.282.5393.1494
   PubMed Web of Science ®Google Scholar
• Choi HW, Bowen SE, Miao Y, et al. Loss of bladder epithelium induced by cytolytic mast cell granules. Immunity. 2016;45(6):1258–1269. doi:10.1016/j.immuni.2016.11.003
   PubMed Web of Science ®Google Scholar
• Hozzari A, Behzadi P, Kerishchi KP, Sholeh M, Sabokroo N. Clinical cases, drug resistance, and virulence genes profiling in Uropathogenic Escherichia coli. J Appl Genet. 2020;61(2):265–273. doi:10.1007/s13353-020-00542-y
   PubMed Web of Science ®Google Scholar
• Leng WW, Chancellor MB. How sacral nerve stimulation neuromodulation works. Urol Clin N Am. 2005;32(1):11–18. doi:10.1016/j.ucl.2004.09.004
   PubMed Web of Science ®Google Scholar
• Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of pain. Cell. 2009;139(2):267–284. doi:10.1016/j.cell.2009.09.028
   PubMed Web of Science ®Google Scholar
• Pinho-Ribeiro FA, Verri WA, Chiu IM. Nociceptor sensory neuron–immune interactions in pain and inflammation. Trends Immunol. 2017;38(1):5–19. doi:10.1016/j.it.2016.10.001
   PubMed Web of Science ®Google Scholar
• Pinho-Ribeiro FA, Baddal B, Haarsma R, et al. Blocking neuronal signaling to immune cells treats streptococcal invasive infection. Cell. 2018;173(5):1083–1097. doi:10.1016/j.cell.2018.04.006
   PubMed Web of Science ®Google Scholar
• Chiu IM, Heesters BA, Ghasemlou N, et al. Bacteria activate sensory neurons that modulate pain and inflammation. Nature. 2013;501(7465):52–57. doi:10.1038/nature12479
   PubMed Web of Science ®Google Scholar
• Baral P, Umans BD, Li L, et al. Nociceptor sensory neurons suppress neutrophil and γδ T cell responses in bacterial lung infections and lethal pneumonia. Nat Med. 2018;24(4):417–426. doi:10.1038/nm.4501
   PubMed Web of Science ®Google Scholar
• Kashem SW, Riedl MS, Yao C, et al. Nociceptive sensory fibers drive interleukin-23 production from CD301b+ dermal dendritic cells and drive protective cutaneous immunity`. Immunity. 2015;43(3):515–526. doi:10.1016/j.immuni.2015.08.016
   PubMed Web of Science ®Google Scholar
• Cavanaugh DJ, Lee H, Lo L, et al. Distinct subsets of unmyelinated primary sensory fibers mediate behavioral responses to noxious thermal and mechanical stimuli. P Natl Acad Sci USA. 2009;106(22):9075–9080. doi:10.1073/pnas.0901507106
   PubMed Web of Science ®Google Scholar
• Shields SD, Cavanaugh DJ, Lee H, Anderson DJ, Basbaum AI. Pain behavior in the formalin test persists after ablation of the great majority of C-fiber nociceptors. Pain. 2010;151(2):422–429. doi:10.1016/j.pain.2010.08.001
   PubMed Web of Science ®Google Scholar
• Levin RM, Wein AJ, Whitmore K, et al. Trypan blue as an indicator of urothelial integrity. Neurourol Urodyn. 1990;9(3):269–279. doi:10.1002/nau.1930090305
   Web of Science ®Google Scholar
• Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14(1):7. doi:10.1186/1471-2105-14-7
   PubMed Web of Science ®Google Scholar
• Diogenes A, Ferraz CCR, Akopian AN, Henry MA, Hargreaves KM. LPS sensitizes TRPV1 via activation of TLR4 in trigeminal sensory neurons. J Dent Res. 2011;90(6):759–764. doi:10.1177/0022034511400225
   PubMed Web of Science ®Google Scholar
• Dale DC, Boxer L, Liles WC. The phagocytes: neutrophils and monocytes. Blood. 2008;112(4):935–945. doi:10.1182/blood-2007-12-077917
   PubMed Web of Science ®Google Scholar
• Kantari C, Pederzoli-Ribeil M, Witko-Sarsat V. The role of neutrophils and monocytes in innate immunity. Contrib Microbiol. 2008;15:118–146. doi:10.1159/000136335
   PubMedGoogle Scholar
• Hampton MB, Kettle AJ, Winterbourn CC. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood. 1998;92(9):3007–3017. doi:10.1182/blood.V92.9.3007
   PubMed Web of Science ®Google Scholar
• Symington JW, Wang C, Twentyman J, et al. ATG16L1 deficiency in macrophages drives clearance of uropathogenic E. Coli in an IL-1β-dependent manner. Mucosal Immunol. 2015;8(6):1388–1399. doi:10.1038/mi.2015.7
   PubMed Web of Science ®Google Scholar
• Russell DG, Huang L, VanderVen BC. Immunometabolism at the interface between macrophages and pathogens. Nat Rev Immunol. 2019;19(5):291–304. doi:10.1038/s41577-019-0124-9
   PubMed Web of Science ®Google Scholar
• Rohde K, Yates RM, Purdy GE, Russell DG. Mycobacterium tuberculosis and the environment within the phagosome. Immunol Rev. 2007;219(1):37–54. doi:10.1111/j.1600-065X.2007.00547.x
   PubMed Web of Science ®Google Scholar
• Veiga-Fernandes H, Artis D. Neuronal-immune system cross-talk in homeostasis. Science. 2018;359(6383):1465–1466. doi:10.1126/science.aap9598
   PubMed Web of Science ®Google Scholar
• Gabanyi I, Muller PA, Feighery L, et al. Neuro-immune interactions drive tissue programming in intestinal macrophages. Cell. 2016;164(3):378–391. doi:10.1016/j.cell.2015.12.023
   PubMed Web of Science ®Google Scholar
• Klose CSN, Mahlakõiv T, Moeller JB, et al. The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation. Nature. 2017;549(7671):282–286. doi:10.1038/nature23676
   PubMed Web of Science ®Google Scholar
• Brain SD, Williams TJ. Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Br J Pharmacol. 1985;86(4):855–860. doi:10.1111/j.1476-5381.1985.tb11107.x
   PubMed Web of Science ®Google Scholar
• Shi X, Wang L, Clark JD, Kingery WS. Keratinocytes express cytokines and nerve growth factor in response to neuropeptide activation of the ERK1/2 and JNK MAPK transcription pathways. Regul Pept. 2013;186:92–103. doi:10.1016/j.regpep.2013.08.001
   PubMedGoogle Scholar
• Behzadi E, Behzadi P. The role of toll-like receptors (TLRs) in urinary tract infections (UTIs). Cent European J Urol. 2016;69(4):404–410. doi:10.5173/ceju.2016.871
   PubMedGoogle Scholar
• Behzadi P, García-Perdomo HA, Karpiński TM. Toll-like receptors: general molecular and structural biology. J Immunol Res. 2021;2021:9914854. doi:10.1155/2021/9914854
   PubMed Web of Science ®Google Scholar
• Bratton DL, Henson PM. Neutrophil clearance: when the party is over, clean-up begins. Trends Immunol. 2011;32(8):350–357. doi:10.1016/j.it.2011.04.009
   PubMed Web of Science ®Google Scholar
• Soehnlein O, Lindbom L. Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol. 2010;10(6):427–439. doi:10.1038/nri2779
   PubMed Web of Science ®Google Scholar
• Benoit M, Desnues B, Mege J. Macrophage polarization in bacterial infections. J Immunol. 2008;181(6):3733–3739. doi:10.4049/jimmunol.181.6.3733
   PubMed Web of Science ®Google Scholar
• Mehta A, Brewington R, Chatterji M, et al. Infection-induced modulation of m1 and m2 phenotypes in circulating monocytes: role in immune monitoring and early prognosis of sepsis. Shock. 2004;22(5):423–430. doi:10.1097/01.shk.0000142184.49976.0c
   PubMed Web of Science ®Google Scholar
• Bozza FA, Salluh JI, Japiassu AM, et al. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care. 2007;11(2):R49. doi:10.1186/cc5783
   PubMed Web of Science ®Google Scholar
• Chen F, Wu W, Millman A, et al. Neutrophils prime a long-lived effector macrophage phenotype that mediates accelerated helminth expulsion. Nat Immunol. 2014;15(10):938–946. doi:10.1038/ni.2984
   PubMed Web of Science ®Google Scholar
• Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. 2013;13(3):159–175. doi:10.1038/nri3399
   PubMed Web of Science ®Google Scholar
• Abtin A, Jain R, Mitchell AJ, et al. Perivascular macrophages mediate neutrophil recruitment during bacterial skin infection. Nat Immunol. 2014;15(1):45–53. doi:10.1038/ni.2769
   PubMed Web of Science ®Google Scholar
• Buckley CD, Gilroy DW, Serhan CN, Stockinger B, Tak PP. The resolution of inflammation. Nat Rev Immunol. 2013;13(1):59–66. doi:10.1038/nri3362
   PubMed Web of Science ®Google Scholar
• Matak I, Lacković Z. Botulinum toxin A, brain and pain. Prog Neurobiol. 2014;119:39–59. doi:10.1016/j.pneurobio.2014.06.001
   PubMed Web of Science ®Google Scholar
• Grando SA, Zachary CB. The non-neuronal and nonmuscular effects of botulinum toxin: an opportunity for a deadly molecule to treat disease in the skin and beyond. Br J Dermatol. 2018;178(5):1011–1019. doi:10.1111/bjd.16080
   PubMed Web of Science ®Google Scholar
• Chermansky CJ, Chancellor MB. Use of botulinum toxin in urologic diseases. Urology. 2016;91:21–32. doi:10.1016/j.urology.2015.12.049
   PubMed Web of Science ®Google Scholar
• Giannantoni A, Mearini E, Del ZM, Proietti S, Porena M. Two-year efficacy and safety of botulinum a toxin intravesical injections in patients affected by refractory painful bladder syndrome. Curr Drug Deliv. 2010;7(1):1–4. doi:10.2174/156720110790396463
   PubMedGoogle Scholar
• Apostolidis A, Dasgupta P, Fowler CJ. Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Eur Urol. 2006;49(4):644–650. doi:10.1016/j.eururo.2005.12.010
   PubMed Web of Science ®Google Scholar